Filing Details
- Accession Number:
- 0001181431-13-059933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-20 16:44:47
- Reporting Period:
- 2013-11-18
- Filing Date:
- 2013-11-20
- Accepted Time:
- 2013-11-20 16:44:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238913 | D Kim Blickenstaff | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-18 | 30,000 | $6.97 | 33,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-18 | 8,100 | $60.57 | 25,457 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-18 | 14,000 | $61.93 | 11,457 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-18 | 7,900 | $62.54 | 3,557 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-18 | 30,000 | $0.00 | 30,000 | $6.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-06-15 | No | 4 | M | Direct |
Footnotes
- The shares were sold at prices ranging from $60.2567 to $61.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $61.285 to $62.27. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $62.275 to $62.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
